{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:32:53Z","timestamp":1791113573133,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4084,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1111\/j.1523-1755.2004.00931.x","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T14:39:43Z","timestamp":1095172783000},"page":"1647-1653","source":"Crossref","is-referenced-by-count":23,"title":["Effect of spironolactone on K+ homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients"],"prefix":"10.1016","volume":"66","author":[{"given":"Luis","family":"Michea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vukusich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa T.","family":"Marusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","article-title":"Reactive and reparative myocardial fibrosis in arterial hypertension in the rat","volume":"26","author":"Brilla","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0020","doi-asserted-by":"crossref","first-page":"E1122","DOI":"10.1152\/ajpendo.2001.281.6.E1122","article-title":"Nontraditional aspects of aldosterone physiology","volume":"281","author":"Ngarmukos","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0025","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"Macfadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0035","first-page":"S87","article-title":"Annual data report: Part VI. Causes of death","volume":"34","author":"United States Renal Data System","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0045","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/ajkd.2001.27392","article-title":"Cardiovascular disease in end-stage renal disease patients","volume":"38","author":"Collins","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0895-7061(99)00066-7","article-title":"Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis","volume":"12","author":"Sato","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041552-200101000-00016","article-title":"Aldosterone in renal disease","volume":"10","author":"Hostetter","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2169\/internalmedicine.40.573","article-title":"Aldosterone as a mediator of progressive renal dysfunction: Evolving perspectives","volume":"40","author":"Epstein","year":"2001","journal-title":"Intern Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"34","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life-threatening hyperkalaemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9343(01)01068-3","article-title":"Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients","volume":"112","author":"Knoll","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1525-139X.2001.00087.x","article-title":"Hyperkalemia in dialysis patients","volume":"14","author":"Ahmed","year":"2001","journal-title":"Semin Dial"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000185725","article-title":"Effect of a simultaneous potassium and carbohydrate load on extrarenal K homeostasis in end-stage renal failure","volume":"53","author":"Alvo","year":"1989","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0095","first-page":"661","article-title":"Factors related to potassium transport in chronic stable renal disease in man","volume":"54","author":"Kahn","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ki.1983.208","article-title":"Blunted kaliuresis after an acute potassium load in patients with chronic renal failure","volume":"24","author":"Perez","year":"1983","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0105","first-page":"125","article-title":"Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis","volume":"12","author":"Fernandez","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ki.1991.5","article-title":"Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats","volume":"39","author":"Goecke","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0115","first-page":"172","article-title":"Control of plasma aldosterone during chronic hemodialysis","volume":"13","author":"Studer","year":"1980","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.1988.194","article-title":"The role of aldosterone in potassium tolerance: Studies in anephric humans","volume":"34","author":"Sugarman","year":"1988","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1081\/JDI-100108195","article-title":"Insulin and mineralocorticoids influence on extrarenal potassium metabolism in chronic hemodialysis patients","volume":"23","author":"Vlassopoulos","year":"2001","journal-title":"Ren Fail"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0130","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/ndt\/gfg388","article-title":"Safety of low-dose spironolactone administration in chronic haemodialysis patients","volume":"18","author":"Saudan","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0135","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/ndt\/gfg413","article-title":"Is spironolactone safe for dialysis patients?","volume":"18","author":"Hussain","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-5299.2003.02397.x","article-title":"Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism","volume":"9","author":"Sica","year":"2003","journal-title":"Congest Heart Fail"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0773.1984.tb03626.x","article-title":"Aspects on pharmacokinetics of some diuretics","volume":"54","author":"Beermann","year":"1984","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005792-198109000-00002","article-title":"Internal potassium balance and the control of the plasma potassium concentration","volume":"60","author":"Sterns","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(86)80120-2","article-title":"Increased secretion of potassium in the rectum of humans with chronic renal failure","volume":"8","author":"Martin","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0160","first-page":"F275","article-title":"Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure","volume":"274","author":"Hatch","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0165","first-page":"207","article-title":"An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure","volume":"80","author":"Hayes","year":"1967","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/cs0730247","article-title":"Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis","volume":"73","author":"Sandle","year":"1987","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0175","first-page":"F103","article-title":"Mechanism of potassium adaptation","volume":"243","author":"Hayslett","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-78-1-13","article-title":"Plasma aldosterone in terminal renal failure","volume":"78","author":"Weidmann","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0954-6820.1977.tb15730.x","article-title":"Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment","volume":"201","author":"Olgaard","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041552-200303000-00006","article-title":"Aldosterone in renal disease","volume":"12","author":"Ibrahim","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0195","first-page":"88","article-title":"The effect of pilocarpine on electrodermal resistance in chronic hemodialyzed patients","volume":"39","author":"Marczewski","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.1995.tb02705.x","article-title":"Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure","volume":"133","author":"Yosipovitch","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000182107","article-title":"Elevated divalent ion concentrations in parotid saliva from chronic renal failure patients","volume":"28","author":"Earlbaum","year":"1981","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0210","first-page":"808","article-title":"Sweat electrolytes in patients with advanced renal failure","volume":"124","author":"Yosipovitch","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000070246","article-title":"SGK1: Aldosterone-induced relay of Na+transport regulation in distal kidney nephron cells","volume":"13","author":"Verrey","year":"2003","journal-title":"Cell Physiol Biochem"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1210\/edrv.23.2.0458","article-title":"The epithelial Na+ channel: Cell surface insertion and retrieval in Na+ homeostasis and hypertension","volume":"23","author":"Snyder","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0225","first-page":"E1072","article-title":"Adrenal-dependent modulation of the catalytic subunit isoforms of the Na+-K+-ATPase in aorta","volume":"275","author":"Michea","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.RES.0000102404.81461.25","article-title":"Aldosteronism and peripheral blood mononuclear cell activation: A neuroendocrine-immune interface","volume":"93","author":"Ahokas","year":"2003","journal-title":"Circ Res"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0235","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M008886200","article-title":"Expression and regulation of normal and polymorphic epithelial sodium channel by human lymphocytes","volume":"276","author":"Bubien","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000013599","article-title":"Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors","volume":"20","author":"Ahuja","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0245","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9343(01)01068-3","article-title":"Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients","volume":"112","author":"Knoll","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0272-6386(99)70181-2","article-title":"A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium","volume":"33","author":"Keilani","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00001573-200307000-00004","article-title":"Managing renal arterial disease and hypertension","volume":"18","author":"Textor","year":"2003","journal-title":"Curr Opin Cardiol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semnephrol.2003.11.001","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: Safety issues","volume":"24","author":"Mangrum","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00931.x_bb0270","first-page":"1292","article-title":"Comparison of extra renal potassium management in hypertensive, diabetic and normal subjects","volume":"125","author":"Michea","year":"1997","journal-title":"Rev Med Chil"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T19:29:31Z","timestamp":1549222171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815502366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0085253815502366"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00931.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}